|Medical news of Remedium.ru portal is the most update information on pharmaceutical and medical equipment market|
Home / News
Pharmstandard signs manufacturing deal with Solvay Pharma's France unit
OJSC Pharmstandard said it has signed a product licence and manufacturing agreement with France-based Solvay Pharma SAS, a subsidiary of Solvay Pharmaceuticals.
The company said the first phase of the agreement includes the import of the compounds purchased from Solvay in France and formulation, tabletting and packaging for two pharmaceutical products, Imudon and IRS 19, by Pharmstandard at its facilities in Russia.
The company said the second phase includes the launch of manufacturing of the compounds at Pharmstandard. It added a decision on the execution of this second phase will be made in due time.
Pharmstandard said it has the right to purchase the intellectual property rights, the process, the know-how and the trademarks of the products from Solvay, adding the option can be executed after the implementation of the second phase.